The thin red line: Angiogenesis in normal and malignant hematopoiesis

被引:79
作者
Bertolini, F
Mancuso, P
Gobbi, A
Pruneri, G
机构
[1] European Inst Oncol, Hematol Oncol Unit, IRCCS, Div Hematol Oncol, I-20141 Milan, Italy
[2] European Inst Oncol, Expt Oncol Div, IRCCS, I-20141 Milan, Italy
[3] European Inst Oncol, Div Pathol Lab Med, IRCCS, I-20141 Milan, Italy
关键词
angiogenesis; vasculogenesis; hematopoiesis; leukemia; lymphoma;
D O I
10.1016/S0301-472X(00)00508-7
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
This review describes the current knowledge about cell subsets involved in vasculogenesis (i.e., differentiation of endothelial cells from mesodermal precursors) and angiogenesis (i.e., blood vessel generation from pre-existing vessels), together with recent findings about angiogenesis and antiangiogenic therapies in hematopoietic malignancies such as leukemia, lymphoma, myeloma, and myelodysplastic syndromes. (C) 2000 International Society for Experimental Hematology. Published by Elsevier Science Inc.
引用
收藏
页码:993 / 1000
页数:8
相关论文
共 96 条
[1]   Cellular vascular endothelial growth factor is a predictor of outcome in patients with acute myeloid leukemia [J].
Aguayo, A ;
Estey, E ;
Kantarjian, H ;
Mansouri, T ;
Gidel, C ;
Keating, M ;
Giles, F ;
Estrov, Z ;
Barlogie, B ;
Albitar, M .
BLOOD, 1999, 94 (11) :3717-3721
[2]  
ALLOUCHE M, 1995, LEUKEMIA, V9, P77
[3]  
Anderson IC, 2000, CANCER RES, V60, P269
[4]   Role of vascular endothelial growth factor/vascular permeability factor in the pathogenesis of Kaposi's sarcoma-associated herpesvirus-infected primary effusion lymphomas [J].
Aoki, Y ;
Tosato, G .
BLOOD, 1999, 94 (12) :4247-4254
[5]   Isolation of putative progenitor endothelial cells for angiogenesis [J].
Asahara, T ;
Murohara, T ;
Sullivan, A ;
Silver, M ;
vanderZee, R ;
Li, T ;
Witzenbichler, B ;
Schatteman, G ;
Isner, JM .
SCIENCE, 1997, 275 (5302) :964-967
[6]   Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization [J].
Asahara, T ;
Masuda, H ;
Takahashi, T ;
Kalka, C ;
Pastore, C ;
Silver, M ;
Kearne, M ;
Magner, M ;
Isner, JM .
CIRCULATION RESEARCH, 1999, 85 (03) :221-228
[7]  
ASANO M, 1995, CANCER RES, V55, P5296
[8]  
Bellamy WT, 1999, CANCER RES, V59, P728
[9]   Endostatin, an antiangiogenic drug, induces tumor stabilization after chemotherapy or anti-CD20 therapy in a NOD/SCID mouse model of human high-grade non-Hodgkin lymphoma [J].
Bertolini, F ;
Fusetti, L ;
Mancuso, P ;
Gobbi, A ;
Corsini, C ;
Ferrucci, PF ;
Martinelli, G ;
Pruneri, G .
BLOOD, 2000, 96 (01) :282-287
[10]   Angiogenic growth factors and endostatin in non-Hodgkin's lymphoma [J].
Bertolini, F ;
Paolucci, M ;
Peccatori, F ;
Cinieri, S ;
Agazzi, A ;
Ferrucci, PF ;
Cocorocchio, E ;
Goldhirsch, A ;
Martinelli, G .
BRITISH JOURNAL OF HAEMATOLOGY, 1999, 106 (02) :504-509